Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA electronic submission guidance

Executive Summary

FDA publishes guidance on providing regulatory submissions in electronic format addressing pharmaceutical production applications and related submissions in the Federal Register Oct. 19. Guidance outlines filing of NDAs, ANDAs, BLAs, INDs, master files and promotional materials using the electronic Common Technical Document. One in a series of documents, the guidance is intended to facilitate use of the eCTD specifications and provides more specificity than previous guidance documents. The agency is accepting comments...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel